These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5744974)

  • 41. [Treatment of peptic ulcer with methyluracil in combination with quateron].
    Vakhrushev IaM
    Sov Med; 1973 Jun; 36(6):140-1. PubMed ID: 4147788
    [No Abstract]   [Full Text] [Related]  

  • 42. [Experiences with a cimetidine depot preparation (Neutronorm retard) in the treatment of peptic ulcer].
    Pesendorfer FX; Salocher C
    Wien Med Wochenschr; 1983; 133(4-5):123-4, 126. PubMed ID: 6344445
    [No Abstract]   [Full Text] [Related]  

  • 43. [Modern views on peptic ulcers].
    Grabowski T
    Wiad Lek; 1970 Nov; 23(21):1891-7. PubMed ID: 4922138
    [No Abstract]   [Full Text] [Related]  

  • 44. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pyrilen and hexonium treatment of patients with ulcer].
    Krechetova EP; Grigor'ev PS
    Vrach Delo; 1965 Oct; 10():149-50. PubMed ID: 5873554
    [No Abstract]   [Full Text] [Related]  

  • 46. [The present state of knowledge on the treatment of peptic diseases with cimetidine].
    Romankiewicz JA; Reidenberg MM
    Internist (Berl); 1981 Dec; 22(12):762-6. PubMed ID: 6797984
    [No Abstract]   [Full Text] [Related]  

  • 47. [Combined use of the central cholinolytic, amedine, and noradrenaline precursor, dioxyphenylalanine (DOPA) in the treatment of ulcer disease].
    Shchedrunov VV; Zavodskaia IS; Zabrodin ON
    Sov Med; 1975 Feb; (2):13-6. PubMed ID: 1145265
    [No Abstract]   [Full Text] [Related]  

  • 48. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer].
    Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D
    Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615
    [No Abstract]   [Full Text] [Related]  

  • 49. Our experience with treatment of duodenal and gastric ulcer with ranitidine (Zantac-Glaxo).
    Yanev P; Yankova R
    Folia Med (Plovdiv); 1985; 27(3):24-7. PubMed ID: 3938752
    [No Abstract]   [Full Text] [Related]  

  • 50. [Action of sultroponium in gastroduodenal pathology. Clinical and biological study].
    Ribet A; Frexinos J
    Therapeutique; 1970 May; 46(5):511-3. PubMed ID: 5430223
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experience of studying the demand for drugs for treating peptic ulcer of the stomach and duodenum in Perm hospitals].
    Voronova PN; Kon'shina TM
    Zdravookhr Ross Fed; 1973 May; 17(5):9-11. PubMed ID: 4268708
    [No Abstract]   [Full Text] [Related]  

  • 52. Ranitidine: a pilot study in Japan.
    Takemoto T; Okazaki Y; Okita K; Namiki M; Ishikawa M; Oshiba S; Kurokawa K
    Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Conservative therapy of gastroduodenal ulcer].
    Ottenjann R
    Minerva Med; 1973 Dec; 64(93):4961-2. PubMed ID: 4798570
    [No Abstract]   [Full Text] [Related]  

  • 54. [New therapeutic trials of sulpiride].
    Félix H
    Sem Hop; 1970 Jun; 46(29):Suppl:15-22. PubMed ID: 4317663
    [No Abstract]   [Full Text] [Related]  

  • 55. [Special form of cytoprotection: a local protective layer on the peptic ulcer].
    Miederer SE; Haberland D
    Wien Med Wochenschr; 1983; 133(4-5):98-103. PubMed ID: 6344446
    [No Abstract]   [Full Text] [Related]  

  • 56. [Gastritis, stomach ulcer, reflux diseases. Motility effective therapy with Motilium].
    Heinkelein J
    ZFA (Stuttgart); 1982 Jun; 58(18):1028-30. PubMed ID: 7113397
    [No Abstract]   [Full Text] [Related]  

  • 57. Caved-S and Ulcedal for peptic ulcer.
    Drug Ther Bull; 1973 Feb; 11(3):10-2. PubMed ID: 4571693
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [What drug treatment to choose for ulcer disease?].
    Bergoz R
    Rev Med Suisse Romande; 1983 Feb; 103(2):99-107. PubMed ID: 6857067
    [No Abstract]   [Full Text] [Related]  

  • 60. [Functional state of the gastric stump after gastrectomy for peptic ulcer].
    Kuznetsov NN; Belitskiĭ AE
    Sov Med; 1970 Oct; 33(10):64-7. PubMed ID: 5504190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.